Panic Disorder

Clinical picture

• Attacks crescendo within ten minutes with palpitations, dyspnea, chest tightness, dizziness, paresthesias, derealization, and fear of dying or losing control.
• Patients present repeatedly to emergency departments and cardiology, often after negative troponins, Holter monitoring, and normal stress tests.
• Nocturnal panic wakes roughly a quarter of patients out of non-REM sleep with no dream trigger, and is frequently misattributed to sleep apnea.
• Between attacks, persistent worry about the next attack and interoceptive vigilance toward heartbeat and breathing dominate daily experience.
• Avoidance spreads outward from exercise and caffeine to crowds, driving, and travel, often reaching criteria for comorbid agoraphobia.
• Many patients over-rely on an unopened bottle of lorazepam or on a trusted companion; that safety signal quietly blocks corrective learning.

Criteria snapshot

• Recurrent unexpected panic attacks, defined as abrupt surges of intense fear peaking within minutes and including at least four of thirteen listed symptoms.
• At least one attack is followed by a month or more of persistent concern about additional attacks or about their meaning and consequences.
• Alternatively or additionally, a month or more of significant maladaptive change in behavior organized around preventing further attacks.
• Not attributable to substances, hyperthyroidism, or cardiopulmonary disease, and not better explained by another mental disorder.
• Panic attacks alone are a specifier applicable across many diagnoses; only recurrent unexpected attacks support panic disorder itself.

Neurobiology

• The fear network centers on amygdala projections to periaqueductal gray, locus coeruleus, parabrachial nucleus, and hypothalamic effector sites.
• The false suffocation alarm model ties panic to hypersensitive medullary CO2 chemoreceptors; 35% CO2 inhalation reliably provokes attacks in patients.
• Sodium lactate, yohimbine, and caffeine challenges provoke panic in patients but not controls, implicating noradrenergic and adenosine signaling.
• Reduced GABA-A benzodiazepine receptor binding and altered serotonergic modulation of brainstem nuclei are documented on PET imaging.
• Heritability approximates 40%, and first-degree relatives carry several-fold elevated risk with no single dominant gene identified.
• Joint hypermobility, mitral valve prolapse, asthma, and vestibular dysfunction show elevated comorbidity rates with panic disorder.

Psychology

• Clark's catastrophic misinterpretation model: benign bodily sensations get read as imminent heart attack, suffocation, fainting, or insanity.
• Anxiety sensitivity, the fear of arousal sensations themselves, is a measurable prospective risk factor and a direct target of treatment.
• Interoceptive conditioning pairs subtle early somatic cues with the full alarm, so attacks feel spontaneous while being internally triggered.
• Safety behaviors such as carrying medication, sitting near exits, or checking the pulse prevent disconfirmation of catastrophic predictions.
• Childhood separation anxiety, early parental loss, and respiratory illness raise later panic risk through learned interoceptive threat value.

Differential & comorbidity

• Exclude arrhythmia, thyrotoxicosis, pheochromocytoma, hypoglycemia, seizure aura, pulmonary embolism, and stimulant or cannabis intoxication.
• Alcohol and benzodiazepine withdrawal reproduce panic faithfully; build a substance timeline before diagnosing a primary anxiety disorder.
• Agoraphobia co-occurs in roughly a third to a half of cases and is coded as a separate diagnosis under DSM-5-TR conventions.
• Depression, other anxiety disorders, bipolar disorder, and alcohol use disorder are the leading comorbidities and each worsens prognosis.
• Panic disorder independently elevates suicide attempt risk; screen directly rather than attributing all distress to the attacks themselves.

Pharmacologic treatment

• SSRIs are first-line: sertraline 25-200 mg/day or escitalopram 5-20 mg/day, begun at half the usual starting dose to limit activation.
• Titrate to target over 2-4 weeks; full response typically requires 8-12 weeks at an adequate dose rather than an early switch.
• Venlafaxine XR 75-225 mg/day is an effective SNRI alternative with comparable efficacy and a need for blood pressure monitoring.
• Benzodiazepines such as clonazepam may bridge the first 2-4 weeks, but they undermine exposure learning and risk dependence if continued.
• Continue medication at least 12 months after remission and taper slowly, since abrupt discontinuation reliably triggers rebound panic.

Psychotherapy

• Panic-focused CBT over 12-15 sessions, combining psychoeducation, cognitive restructuring, and exposure, is the gold-standard treatment.
• Interoceptive exposure using hyperventilation, spinning, and straw breathing is the active ingredient and is also the most commonly omitted one.
• Breathing retraining is optional and can itself become a safety behavior; keep it subordinate to direct exposure to arousal sensations.
• Panic-focused psychodynamic psychotherapy has randomized trial support as an alternative for patients who decline or fail CBT.
• Gains from CBT persist at two-year follow-up and protect against relapse better than medication stopped at the same time point.

Adjunct options

• Monitor with the Panic Disorder Severity Scale plus a daily attack diary recording triggers, duration, and safety behaviors used.
• Eliminate escalating caffeine, nicotine, and energy drinks; graded aerobic exercise doubles as naturalistic interoceptive exposure.
• Coordinate with cardiology and emergency clinicians to stop repeat workups that keep reinforcing the catastrophic illness narrative.
• Digital and telehealth CBT protocols show non-inferior outcomes and reach patients whose avoidance prevents office attendance.
• Reserve intensive outpatient or partial hospitalization for panic with severe housebound agoraphobic avoidance or active suicidality.

Clinical pearls

• Interoceptive exposure is the mechanism; CBT without it usually explains why treatment stalled.
• A rescue benzodiazepine carried but never used still works as a safety signal and blocks learning.
• Nocturnal panic is not sleep apnea; ask about waking in abrupt terror with no dream content.